Psychoactive Substances Act 2016
Psychoactive Substances Act 2016
The Psychoactive Substances Act 2016 is a piece of legislation enacted by the UK Parliament that aims to curb the proliferation and use of psychoactive substances, often referred to as "legal highs". Prior to the act, these substances, which mimic the effects of illegal drugs but were not covered by existing drug laws, were readily available and legal to purchase. The act received Royal Assent on 28 January 2016 and came into force on 26 May 2016.
Overview[edit | edit source]
The Psychoactive Substances Act 2016 makes it an offense to produce, supply, offer to supply, possess with intent to supply, import, or export any substance deemed to be psychoactive, with exceptions for substances like alcohol, tobacco, caffeine, food, and medical products, which are regulated under other legislation. The act defines a psychoactive substance as any substance which is capable of producing a psychoactive effect in a person who consumes it, where a psychoactive effect is described as stimulating or depressing the person’s central nervous system, affecting the person’s mental functioning or emotional state.
Key Provisions[edit | edit source]
- Blanket Ban: The act introduces a blanket ban on the production, distribution, sale, and supply of psychoactive substances in the UK.
- Exemptions: Certain substances, including alcohol, tobacco, nicotine, caffeine, and medical products, are exempt from the ban.
- Penalties: Individuals found guilty of offenses under the act can face up to 7 years in prison.
- Enforcement: The act grants powers to the police, Border Force, and other authorities to seize and destroy psychoactive substances, enter premises, and conduct searches.
Criticism and Controversy[edit | edit source]
The Psychoactive Substances Act 2016 has been subject to criticism from various quarters. Critics argue that the act's broad definition of psychoactive substances could lead to legal challenges and difficulties in enforcement. There are also concerns about the act pushing the sale of psychoactive substances into the black market, potentially increasing the risks associated with their use. Furthermore, the act has sparked a debate about the effectiveness of prohibitionist drug policies versus harm reduction approaches.
Impact[edit | edit source]
The impact of the Psychoactive Substances Act 2016 has been mixed. While there has been a reported decrease in the availability of legal highs in high street shops, evidence suggests that the use of psychoactive substances has moved to the black market. The act has also led to an increase in the confiscation of substances at UK borders.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD